619 related articles for article (PubMed ID: 25586402)
1. Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population.
Hendricks PS; Thorne CB; Clark CB; Coombs DW; Johnson MW
J Psychopharmacol; 2015 Mar; 29(3):280-8. PubMed ID: 25586402
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and epidemiological associates of novel psychedelic use in the United States adult population.
Sexton JD; Crawford MS; Sweat NW; Varley A; Green EE; Hendricks PS
J Psychopharmacol; 2019 Sep; 33(9):1058-1067. PubMed ID: 30816808
[TBL] [Abstract][Full Text] [Related]
3. Psychedelics not linked to mental health problems or suicidal behavior: a population study.
Johansen PØ; Krebs TS
J Psychopharmacol; 2015 Mar; 29(3):270-9. PubMed ID: 25744618
[TBL] [Abstract][Full Text] [Related]
4. MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults.
Jones GM; Nock MK
J Psychopharmacol; 2022 Jan; 36(1):46-56. PubMed ID: 34983249
[TBL] [Abstract][Full Text] [Related]
5. The relationships of classic psychedelic use with criminal behavior in the United States adult population.
Hendricks PS; Crawford MS; Cropsey KL; Copes H; Sweat NW; Walsh Z; Pavela G
J Psychopharmacol; 2018 Jan; 32(1):37-48. PubMed ID: 29039233
[TBL] [Abstract][Full Text] [Related]
6. Psychedelics and mental health: a population study.
Krebs TS; Johansen PØ
PLoS One; 2013; 8(8):e63972. PubMed ID: 23976938
[TBL] [Abstract][Full Text] [Related]
7. Population Survey Data Informing the Therapeutic Potential of Classic and Novel Phenethylamine, Tryptamine, and Lysergamide Psychedelics.
Sexton JD; Nichols CD; Hendricks PS
Front Psychiatry; 2019; 10():896. PubMed ID: 32116806
[TBL] [Abstract][Full Text] [Related]
8. Suicidal thoughts and behaviors among adults aged ≥18 years--United States, 2008-2009.
Crosby AE; Han B; Ortega LA; Parks SE; Gfroerer J;
MMWR Surveill Summ; 2011 Oct; 60(13):1-22. PubMed ID: 22012169
[TBL] [Abstract][Full Text] [Related]
9. Associations between lifetime classic psychedelic use and markers of physical health.
Simonsson O; Sexton JD; Hendricks PS
J Psychopharmacol; 2021 Apr; 35(4):447-452. PubMed ID: 33719688
[TBL] [Abstract][Full Text] [Related]
10. The association of psychedelic use and opioid use disorders among illicit users in the United States.
Pisano VD; Putnam NP; Kramer HM; Franciotti KJ; Halpern JH; Holden SC
J Psychopharmacol; 2017 May; 31(5):606-613. PubMed ID: 28196428
[TBL] [Abstract][Full Text] [Related]
11. The moderating effect of psychedelics on the prospective relationship between prescription opioid use and suicide risk among marginalized women.
Argento E; Braschel M; Walsh Z; Socias ME; Shannon K
J Psychopharmacol; 2018 Dec; 32(12):1385-1391. PubMed ID: 30255717
[TBL] [Abstract][Full Text] [Related]
12. Tobacco Use and 12-Month Suicidality Among Adults in the United States.
Han B; Compton WM; Blanco C
Nicotine Tob Res; 2017 Jan; 19(1):39-48. PubMed ID: 27190402
[TBL] [Abstract][Full Text] [Related]
13. Suicidal ideation and suicide attempts among adults with psychotic experiences: data from the Collaborative Psychiatric Epidemiology Surveys.
DeVylder JE; Lukens EP; Link BG; Lieberman JA
JAMA Psychiatry; 2015 Mar; 72(3):219-25. PubMed ID: 25715312
[TBL] [Abstract][Full Text] [Related]
14. Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA and psilocybin) and psychological distress and suicidality.
Jones GM; Nock MK
Sci Rep; 2022 Oct; 12(1):16976. PubMed ID: 36216840
[TBL] [Abstract][Full Text] [Related]
15. On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review.
Zeifman RJ; Singhal N; Breslow L; Weissman CR
ACS Pharmacol Transl Sci; 2021 Apr; 4(2):436-451. PubMed ID: 33860173
[TBL] [Abstract][Full Text] [Related]
16. Past-year hallucinogen use in relation to psychological distress, depression, and suicidality among US adults.
Yang KH; Han BH; Palamar JJ
Addict Behav; 2022 Sep; 132():107343. PubMed ID: 35525189
[TBL] [Abstract][Full Text] [Related]
17. Psilocybin, psychological distress, and suicidality.
Hendricks PS; Johnson MW; Griffiths RR
J Psychopharmacol; 2015 Sep; 29(9):1041-3. PubMed ID: 26395582
[No Abstract] [Full Text] [Related]
18. Suicidality and sexual orientation among men in Switzerland: findings from 3 probability surveys.
Wang J; Häusermann M; Wydler H; Mohler-Kuo M; Weiss MG
J Psychiatr Res; 2012 Aug; 46(8):980-6. PubMed ID: 22591853
[TBL] [Abstract][Full Text] [Related]
19. Associations between MDMA/ecstasy, classic psychedelics, and suicidal thoughts and behaviors in a sample of U.S. adolescents.
Jones G; Arias D; Nock M
Sci Rep; 2022 Dec; 12(1):21927. PubMed ID: 36535992
[TBL] [Abstract][Full Text] [Related]
20. Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalised women in a Canadian setting.
Argento E; Strathdee SA; Tupper K; Braschel M; Wood E; Shannon K
BMJ Open; 2017 Sep; 7(9):e016025. PubMed ID: 28939573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
